<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
    <link rel="stylesheet" href="../css/uswds.min.css">
    <link rel="stylesheet" href="../css/style.css">
    <link rel="stylesheet" href="css/uswds.min.css">
    <link rel="stylesheet" href="css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="/">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="/">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="/html/titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="/html/parts/21CFR524.html">Part 524
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 524.154  Bacitracin, neomycin, and polymyxin B ophthalmic ointment.
                            </h3>
                            <p class="depth0"><em>(a)</em> Specifications. Each gram of ointment contains:</p><p class="depth0"><em>(1)</em> 500 units bacitracin, 3.5 milligrams (mg) neomycin sulfate (equivalent to 3.5 mg neomycin base), and 10,000 units polymyxin B sulfate; or</p><p class="depth0"><em>(2)</em> 400 units bacitracin zinc, 5 mg neomycin sulfate (equivalent to 3.5 mg neomycin base), and 10,000 units polymyxin B sulfate.</p><p class="depth0"><em>(b)</em> Sponsors. See sponsor numbers in Sec. 510.600(c) of this chapter as follows:</p><p class="depth0"><em>(1)</em> No. 054771 for use of product described in paragraph (a)(1) as in paragraph (c) of this section.</p><p class="depth0"><em>(2)</em> Nos. 000061, 043264, and 059399 for use of product described in paragraph (a)(2) as in paragraph (c) of this section.</p><p class="depth0"><em>(c)</em> Conditions of use in dogs and cats--(1) Amount. Apply a thin film over the cornea 3 or 4 times daily.</p><p class="depth0"><em>(2)</em> Indications for use. Treatment of superficial bacterial infections of the eyelid and conjunctiva of dogs and cats when due to susceptible organisms.</p><p class="depth0"><em>(3)</em> Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[57 FR 37333, Aug. 18, 1992, as amended at 61 FR 8873, Mar. 6, 1996; 62 FR 61625, Nov. 19, 1997; 77 FR 64717, Oct. 23, 2012; 79 FR 10967, Feb. 27, 2014; 80 FR 61297, Oct. 13, 2015]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>. Code available <a href="#">on Github.</a></h5>
      </div>
    </div>
  </footer>
  </body>
</html>
